Chugai Pharmaceutical Co., Ltd. (CHGCY)
21.82
-0.37
(-1.67%)
USD |
OTCM |
Aug 24, 16:00
Chugai Pharmaceutical Gross Profit Margin (Quarterly) : 69.49% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 69.49% |
| March 31, 2026 | 71.16% |
| December 31, 2025 | 74.72% |
| September 30, 2025 | 69.91% |
| June 30, 2025 | 69.63% |
| March 31, 2025 | 69.55% |
| December 31, 2024 | 68.78% |
| September 30, 2024 | 73.32% |
| June 30, 2024 | 72.16% |
| March 31, 2024 | 69.21% |
| December 31, 2023 | 66.38% |
| September 30, 2023 | 69.66% |
| June 30, 2023 | 65.72% |
| March 31, 2023 | 51.53% |
| December 31, 2022 | 51.45% |
| September 30, 2022 | 69.33% |
| June 30, 2022 | 66.12% |
| March 31, 2022 | 57.41% |
| December 31, 2021 | 65.84% |
| September 30, 2021 | 63.73% |
| June 30, 2021 | 69.26% |
| March 31, 2021 | 67.22% |
| December 31, 2020 | 65.66% |
| September 30, 2020 | 66.72% |
| June 30, 2020 | 62.60% |
| Date | Value |
|---|---|
| March 31, 2020 | 65.85% |
| December 31, 2019 | 63.92% |
| September 30, 2019 | 60.75% |
| June 30, 2019 | 61.40% |
| March 31, 2019 | 58.58% |
| December 31, 2018 | 55.76% |
| September 30, 2018 | 53.34% |
| June 30, 2018 | 52.62% |
| March 31, 2018 | 56.70% |
| December 31, 2017 | 53.83% |
| September 30, 2017 | 51.76% |
| June 30, 2017 | 52.65% |
| March 31, 2017 | 51.25% |
| December 31, 2016 | 50.81% |
| September 30, 2016 | 48.39% |
| June 30, 2016 | 49.98% |
| March 31, 2016 | 48.97% |
| December 31, 2015 | 53.19% |
| September 30, 2015 | 51.81% |
| June 30, 2015 | 51.67% |
| March 31, 2015 | 50.68% |
| December 31, 2014 | 52.45% |
| September 30, 2014 | 50.89% |
| June 30, 2014 | 51.60% |
| March 31, 2014 | 55.01% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 57.57% |
| Daiichi Sankyo Co., Ltd. | 78.37% |
| Eisai Co., Ltd. | 78.20% |
| Santen Pharmaceutical Co., Ltd. | 54.66% |
| Ono Pharmaceutical Co., Ltd. | 75.31% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.88% |
| Return on Assets | 20.19% |
| Return on Invested Capital | 23.67% |
| Profit Margin (Quarterly) | 34.06% |
| Operating Margin (Quarterly) | 48.47% |
| Return on Net Operating Assets | 40.94% |